Lyle Melenka

Sherwood Park, 
CA 
Clinical Trials:Currently Recruiting for 1 Trial
Sherwood Park, 
CA 

Overview

Lyle Melenka practices practicing medicine in Canada.

His clinical expertise encompasses Asthma and Asbestosis.

He is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Sherwood Park, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

International Severe Asthma Registry: Canadian Cohort
International Severe Asthma Registry: Canadian Cohort
Enrollment Status: Recruiting
Publish Date: May 01, 2026
Patient Outcomes Real World Evidence Registry (POWER): Patient Reported Outcomes in a Cohort of Canadian Adults With Severe Eosinophilic Asthma on Benralizumab.
Patient Outcomes Real World Evidence Registry (POWER): Patient Reported Outcomes in a Cohort of Canadian Adults With Severe Eosinophilic Asthma on Benralizumab.
Enrollment Status: Completed
Publish Date: July 01, 2024
Intervention Type: Other
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
View 2 Less Clinical Trial

11 Total Publications

Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR).
Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR).
Journal: The World Allergy Organization journal
Published: December 18, 2024

Frequently Asked Questions about Lyle Melenka

Is Lyle Melenka a top-rated expert for Asthma?

MediFind is an objective health platform that identifies experts based on real-world data. Lyle Melenka is classified as an Experienced expert for Asthma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lyle Melenka participate in research or clinical trials?

Yes. Lyle Melenka has published 11 articles and abstracts on conditions like Asthma. You can view a list of Lyle Melenka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Melenka's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile